for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Semler Scientific Inc

SMLR.OQ

Latest Trade

96.56USD

Change

-0.42(-0.43%)

Volume

5,750

Today's Range

95.99

 - 

98.79

52 Week Range

90.52

 - 

151.00

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
96.98
Open
95.99
Volume
5,750
3M AVG Volume
1.09
Today's High
98.79
Today's Low
95.99
52 Week High
151.00
52 Week Low
90.52
Shares Out (MIL)
6.76
Market Cap (MIL)
655.36
Forward P/E
41.09
Dividend (Yield %)
--

Next Event

Q4 2021 Semler Scientific Inc Earnings Release

Latest Developments

More

Semler Scientific Reports Q3 Earnings Per Share Of $0.51

Semler Scientific To Start Trading On Nasdaq Under Symbol "SMLR"

Semler Reports Q2 2021 Financial Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Semler Scientific Inc

Semler Scientific, Inc. provides technology solutions to healthcare providers. The Company develops, manufactures and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular-testing product, QuantaFlo, which measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease, or PAD. QuantaFlo is an approximately four-minute in-office blood flow test. The healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger much like pulse oximetry devices. It has placed its QuantaFlo product with healthcare insurance plans, integrated delivery networks, independent physician groups and companies contracting with the healthcare industry, such as risk assessment groups.

Industry

Medical Equipment & Supplies

Contact Info

2340-2348 WALSH AVENUE, SUITE 2344

SANTA CLARA, CA

95051

United States

+1.408.6274557

http://semlerscientific.com/

Executive Leadership

Douglas Murphy-Chutorian

Chief Executive Officer, Director

Andrew B. Weinstein

Senior Vice President - Finance and Accounting

Daniel E. Conger

Vice President - Finance

Arthur N. Leibowitz

Independent Director

Daniel S. Messina

Independent Director

Key Stats

1.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020

0.0K

2021(E)

0.1K
EPS (USD)

2018

0.660

2019

1.880

2020

1.740

2021(E)

2.360
Price To Earnings (TTM)
37.35
Price To Sales (TTM)
12.24
Price To Book (MRQ)
14.89
Price To Cash Flow (TTM)
30.14
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
63.32
Return on Equity (TTM)
53.42

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up